Literature DB >> 12439890

Correlation between abnormal cardiac physical examination and echocardiographic findings in neonates with Down syndrome.

Doff B McElhinney1, Michele Straka, Elizabeth Goldmuntz, Elaine H Zackai.   

Abstract

Congenital heart disease is present in 40-50% of individuals with Down syndrome. Although cardiovascular evaluation is a standard component of the diagnostic work-up in patients with Down syndrome, the value of routine neonatal echocardiography in this population is debated. We studied 114 neonates with Down syndrome who underwent both cardiac physical examination and echocardiography in the neonatal period to assess the accuracy of physical examination for identifying cardiovascular anomalies in this population. We retrospectively reviewed physical examination records and echocardiogram reports in 114 neonates with Down syndrome and trisomy 21. A patient was considered to have an abnormal cardiac physical examination if there was a pathologic cardiac murmur and/or cyanosis or an abnormal systemic arterial oxygen saturation. The median age at the time of physical examination was 2 days (1-30 days). Physical examination findings suggestive of cardiovascular pathology were noted in 77 patients (68%), with an abnormal cardiac murmur in 34 (30%), cyanosis and/or a pulse oximeter reading of < or = 92% in 35 (31%), and both in 7 (6%). The echocardiogram was abnormal in 75 patients (66%), with an atrioventricular septal defect in 33, tetralogy of Fallot in 13, both of these anomalies in 2, a ventricular septal defect in 17, a patent ductus arteriosus beyond 7 days of age in 7, and other anomalies in 2. The sensitivity of physical examination findings for detection of cardiovascular anomalies was 80% and the specificity was 56%. The positive predictive value of an abnormal physical examination was 78% and the negative predictive value of a normal physical examination was 59%. Fifteen patients had a normal physical examination but an abnormal echocardiogram, nine of whom eventually required surgery. Physical examination alone is not sufficient to identify cardiovascular anomalies in neonates with Down syndrome. In the newborn with Down syndrome, the potential benefits of early diagnosis, in the context of physical examination findings, should be considered in determining whether an echocardiogram should be performed in the neonatal period. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 12439890     DOI: 10.1002/ajmg.10803

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  13 in total

1.  Screening for Congenital Heart Disease in Infants with Down Syndrome: Is Universal Echocardiography Necessary?

Authors:  Soujanya Bogarapu; Nelangi M Pinto; Susan P Etheridge; Xiaoming Sheng; Kirk N Liesemer; Paul C Young; Elizabeth V Saarel
Journal:  Pediatr Cardiol       Date:  2016-06-09       Impact factor: 1.655

Review 2.  Echocardiography in children with Down syndrome.

Authors:  Mohammed A Al-Biltagi
Journal:  World J Clin Pediatr       Date:  2013-11-08

3.  Postnatal lethality and cardiac anomalies in the Ts65Dn Down syndrome mouse model.

Authors:  Clara S Moore
Journal:  Mamm Genome       Date:  2006-10-03       Impact factor: 2.957

4.  The Incidence of Cardiac Lesions among Children with Down's Syndrome in Jamaica - A Prospective Study.

Authors:  C Scott; M Thame
Journal:  West Indian Med J       Date:  2015-08-26       Impact factor: 0.171

5.  Usefulness of Postnatal Echocardiography in Patients with Down Syndrome with Normal Fetal Echocardiograms.

Authors:  Amy Cooper; Kacy Sisco; Carl H Backes; Marc Dutro; Ruth Seabrook; Stephanie L Santoro; Clifford L Cua
Journal:  Pediatr Cardiol       Date:  2019-09-20       Impact factor: 1.655

Review 6.  Adults with genetic syndromes and cardiovascular abnormalities: clinical history and management.

Authors:  Angela E Lin; Craig T Basson; Elizabeth Goldmuntz; Pilar L Magoulas; Deborah A McDermott; Donna M McDonald-McGinn; Elspeth McPherson; Colleen A Morris; Jacqueline Noonan; Catherine Nowak; Mary Ella Pierpont; Reed E Pyeritz; Alan F Rope; Elaine Zackai; Barbara R Pober
Journal:  Genet Med       Date:  2008-07       Impact factor: 8.822

7.  Widespread impairment of cell proliferation in the neonate Ts65Dn mouse, a model for Down syndrome.

Authors:  A Contestabile; T Fila; A Cappellini; R Bartesaghi; E Ciani
Journal:  Cell Prolif       Date:  2009-04       Impact factor: 6.831

8.  Prevalence of congenital heart defects and persistent pulmonary hypertension of the neonate with Down syndrome.

Authors:  Michel Emile Weijerman; A Marceline van Furth; Maurike D van der Mooren; Miriam M van Weissenbruch; Lukas Rammeloo; Chantal J M Broers; Reinoud J B J Gemke
Journal:  Eur J Pediatr       Date:  2010-04-23       Impact factor: 3.183

9.  Longitudinal assessment of cardiac function in infants with Down's syndrome using novel echocardiography techniques - project protocol.

Authors:  Aisling Smith; Eleanor Molloy; Jan Miletin; Anna Curley; Joanne Balfe; Orla Franklin; Afif El-Khuffash
Journal:  HRB Open Res       Date:  2020-10-21

Review 10.  The power of comparative and developmental studies for mouse models of Down syndrome.

Authors:  Clara S Moore; Randall J Roper
Journal:  Mamm Genome       Date:  2007-07-26       Impact factor: 2.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.